Abstract
Summary What is known and objectives To date, no case of headache has been reported with enoxaparin. We present the case of a 60-years-old man, who developed enoxaparin-induced throbbing headache and discuss the possible pharmacological mechanisms. We provide an analysis of enoxaparin-induced headache in three international databases. Case summary A few hours after the subcutaneous administration of this drug at therapeutic dose, the patient experienced throbbing headache. Rechallenge on two other separate occasions separated by several days produced the same effect although with reduced intensity when the dose was lowered. The Naranjo Algorithm indicated a 'certain' relationship. What is new and conclusion We report a case of throbbing headache associated with the use of enoxaparin; with the increasing use of enoxaparin, physicians who prescribe this drug should be aware of this potential ADR. We suggest that it is a heparin class-effect, and therefore, a more general caution is also appropriate. Enoxaparin is generally safe but side-effects related to pharmacological effect could occur, i.e haemorrhages and thrombocytopenia. We report a case of enoxaparin- induced throbbing headache, an unknown ADR, likely due to the stimulation of the release of nitric oxide (NO) and the increase of cyclic guanosine monophosphate (cGMP).
| Original language | English |
|---|---|
| Pages (from-to) | 342-344 |
| Number of pages | 3 |
| Journal | Journal of Clinical Pharmacy and Therapeutics |
| Volume | 40 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Jun 1 2015 |
Fingerprint
Keywords
- adverse drug reaction
- enoxaparin
- headache
- pharmacovigilance
ASJC Scopus subject areas
- Pharmacology (medical)
- Pharmacology
- Medicine(all)
Cite this
Throbbing headache associated with enoxaparin administration : A case report, a review of pharmacovigilance databases for similar cases and possible mechanisms. / Brusadelli, T.; Carnovale, C.; Gentili, M.; Borsadoli, C.; Speziali, A.; Perrone, V.; Pellegrino, P.; Antoniazzi, S.; Pozzi, M.; Radice, S.; Clementi, E.
In: Journal of Clinical Pharmacy and Therapeutics, Vol. 40, No. 3, 01.06.2015, p. 342-344.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Throbbing headache associated with enoxaparin administration
T2 - A case report, a review of pharmacovigilance databases for similar cases and possible mechanisms
AU - Brusadelli, T.
AU - Carnovale, C.
AU - Gentili, M.
AU - Borsadoli, C.
AU - Speziali, A.
AU - Perrone, V.
AU - Pellegrino, P.
AU - Antoniazzi, S.
AU - Pozzi, M.
AU - Radice, S.
AU - Clementi, E.
PY - 2015/6/1
Y1 - 2015/6/1
N2 - Summary What is known and objectives To date, no case of headache has been reported with enoxaparin. We present the case of a 60-years-old man, who developed enoxaparin-induced throbbing headache and discuss the possible pharmacological mechanisms. We provide an analysis of enoxaparin-induced headache in three international databases. Case summary A few hours after the subcutaneous administration of this drug at therapeutic dose, the patient experienced throbbing headache. Rechallenge on two other separate occasions separated by several days produced the same effect although with reduced intensity when the dose was lowered. The Naranjo Algorithm indicated a 'certain' relationship. What is new and conclusion We report a case of throbbing headache associated with the use of enoxaparin; with the increasing use of enoxaparin, physicians who prescribe this drug should be aware of this potential ADR. We suggest that it is a heparin class-effect, and therefore, a more general caution is also appropriate. Enoxaparin is generally safe but side-effects related to pharmacological effect could occur, i.e haemorrhages and thrombocytopenia. We report a case of enoxaparin- induced throbbing headache, an unknown ADR, likely due to the stimulation of the release of nitric oxide (NO) and the increase of cyclic guanosine monophosphate (cGMP).
AB - Summary What is known and objectives To date, no case of headache has been reported with enoxaparin. We present the case of a 60-years-old man, who developed enoxaparin-induced throbbing headache and discuss the possible pharmacological mechanisms. We provide an analysis of enoxaparin-induced headache in three international databases. Case summary A few hours after the subcutaneous administration of this drug at therapeutic dose, the patient experienced throbbing headache. Rechallenge on two other separate occasions separated by several days produced the same effect although with reduced intensity when the dose was lowered. The Naranjo Algorithm indicated a 'certain' relationship. What is new and conclusion We report a case of throbbing headache associated with the use of enoxaparin; with the increasing use of enoxaparin, physicians who prescribe this drug should be aware of this potential ADR. We suggest that it is a heparin class-effect, and therefore, a more general caution is also appropriate. Enoxaparin is generally safe but side-effects related to pharmacological effect could occur, i.e haemorrhages and thrombocytopenia. We report a case of enoxaparin- induced throbbing headache, an unknown ADR, likely due to the stimulation of the release of nitric oxide (NO) and the increase of cyclic guanosine monophosphate (cGMP).
KW - adverse drug reaction
KW - enoxaparin
KW - headache
KW - pharmacovigilance
UR - http://www.scopus.com/inward/record.url?scp=84928213196&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84928213196&partnerID=8YFLogxK
U2 - 10.1111/jcpt.12257
DO - 10.1111/jcpt.12257
M3 - Article
C2 - 25726970
AN - SCOPUS:84928213196
VL - 40
SP - 342
EP - 344
JO - Journal of Clinical Pharmacy and Therapeutics
JF - Journal of Clinical Pharmacy and Therapeutics
SN - 0269-4727
IS - 3
ER -